pioglitazone has been researched along with Carcinoma, Lewis Lung in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Carcinoma, Lewis Lung: A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mori, A | 1 |
Sakurai, H | 1 |
Choo, MK | 1 |
Obi, R | 1 |
Koizumi, K | 1 |
Yoshida, C | 1 |
Shimada, Y | 1 |
Saiki, I | 1 |
1 other study available for pioglitazone and Carcinoma, Lewis Lung
Article | Year |
---|---|
Severe pulmonary metastasis in obese and diabetic mice.
Topics: Animals; Carcinoma, Lewis Lung; Cell Line, Tumor; Hypoglycemic Agents; Killer Cells, Natural; Leptin | 2006 |